phenobarbital has been researched along with prochlorperazine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (70.83) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Honigberg, IL; Justice, EL; Plunkett, RD; Smith, AP; Stewart, JT | 1 |
| Kutt, H; Penry, JK | 1 |
| Calcet, J; Corriol, J; Dimov, S; Joanny, P | 1 |
| Kutt, H; Verebely, K | 1 |
| Ihamäki, T; Jussila, J; Kalima, T; Salmi, HJ; Siurala, M; Tarpila, S | 1 |
| Spector, RG | 1 |
| Hill, RM; Horning, MG; McCulley, LB; Morgan, NF; Verniaud, WM | 1 |
| Beal, DD; Bryan, GT; Ramirez, G; Skibba, JL | 1 |
| Borgstedt, AD; Rosen, MG | 1 |
| CASEY, JF; HOLLISTER, LE; KLETT, CJ; LASKY, JJ | 1 |
| PLOTNIKOFF, N | 1 |
| MARKS, J | 1 |
| WHITMAN, RM | 1 |
| WINBERG, J | 1 |
| MCLAUGHLIN, BE | 1 |
| BRILL, NQ; EPSTEIN, LJ; FORGY, EW; KOEGLER, RR | 1 |
| BAN, TA; LEHMANN, HE | 1 |
2 review(s) available for phenobarbital and prochlorperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Usefulness of blood levels of antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Chloramphenicol; Chlordiazepoxide; Chlorpromazine; Chromatography, Gas; Dextropropoxyphene; Diazepam; Dicumarol; Disulfiram; Drug Interactions; Epilepsy; Ethosuximide; Humans; Isoniazid; Methylphenidate; Phenethylamines; Phenobarbital; Phenylbutazone; Phenytoin; Primidone; Prochlorperazine; Sulfamethizole; Sulfaphenazole; Thiazines | 1974 |
22 other study(ies) available for phenobarbital and prochlorperazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Liquid chromatography in pharmaceutical analysis IV: determination of antispasmodic mixtures.
Topics: Atropine; Chemical Phenomena; Chemistry; Chlordiazepoxide; Chromatography; Drug Combinations; Hydrogen-Ion Concentration; Methods; Parasympatholytics; Phenobarbital; Prochlorperazine; Propantheline; Quaternary Ammonium Compounds; Quinuclidines; Scopolamine | 1975 |
The protection against the cerebral and pulmonary effects of hyperbaric oxygen by pharmacological agents and lithium salts in mice.
Topics: Acetates; Aminobutyrates; Animals; Anticonvulsants; Antipsychotic Agents; Brain; Chlorpromazine; Female; Hydroxybutyrates; Hyperbaric Oxygenation; Lithium; Lung; Mice; Oxazoles; Phenobarbital; Phenytoin; Prochlorperazine; Promazine; Pulmonary Edema; Seizures; Water | 1973 |
Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.
Topics: Adenosine Triphosphate; Animals; Azides; Biotransformation; Chlordiazepoxide; Chlorpromazine; Dextropropoxyphene; Diazepam; Diethylstilbestrol; Dimenhydrinate; Disulfiram; Hydantoins; Hydrogen-Ion Concentration; In Vitro Techniques; Isoniazid; Kinetics; Male; Methylene Blue; Microsomes, Liver; NAD; NADP; Oxygen; Phenobarbital; Phenytoin; Proadifen; Prochlorperazine; Rats; Sodium; Temperature | 1970 |
Premedication for endoscopy: a controlled trial.
Topics: Anesthesia, Local; Anxiety; Atropine; Diazepam; Endoscopy; Esophagoscopy; Gastroscopy; Humans; Nausea; Phenobarbital; Premedication; Prochlorperazine; Time Factors | 1974 |
Effects of formyl tetrahydrofolic acid and noradrenaline on the oxygen consumption of rat brain synaptosome-mitochondrial preparations.
Topics: Acetylcholine; Animals; Cerebral Cortex; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Folic Acid; Histamine; Isoproterenol; Kinetics; Leucovorin; Microsomes; Models, Structural; Norepinephrine; Oxygen Consumption; Phenobarbital; Prochlorperazine; Rats; Synaptosomes | 1972 |
Infants exposed in utero to antiepileptic drugs. A prospective study.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Amitriptyline; Amniotic Fluid; Anticonvulsants; Chromatography, Gas; Diazepam; Epilepsy; Ethosuximide; Female; Fetus; Growth Disorders; Humans; Hydantoins; Infant, Newborn; Mass Spectrometry; Mephobarbital; Meprobamate; Milk, Human; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Primidone; Prochlorperazine; Prospective Studies; Substance Withdrawal Syndrome; Succinimides; Time Factors | 1974 |
N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.
Topics: Animals; Antineoplastic Agents; Carbon Dioxide; Carbon Isotopes; Formaldehyde; Humans; Imidazoles; In Vitro Techniques; Liver; Male; Microsomes, Liver; Phenobarbital; Prochlorperazine; Protein Biosynthesis; Rats | 1970 |
Medication during labor correlated with behavior and EEG of the newborn.
Topics: Anesthesia, Obstetrical; Behavior; Electroencephalography; Female; Humans; Infant, Newborn; Meperidine; Morphine; Phenobarbital; Pregnancy; Prochlorperazine; Promethazine | 1968 |
Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital.
Topics: Antipsychotic Agents; Chlorpromazine; Perphenazine; Phenobarbital; Phenothiazines; Prochlorperazine; Schizophrenia; Tranquilizing Agents; Triflupromazine | 1960 |
EFFECT OF NEUROTROPIC DRUGS ON A NON-CONDITIONED AVOIDANCE RESPONSE.
Topics: Animals; Avoidance Learning; Behavior, Animal; Biological Assay; Chlorpromazine; Histamine H1 Antagonists; Imipramine; Muscle Relaxants, Central; Noise; Perphenazine; Phenobarbital; Prochlorperazine; Rats; Research; Tranquilizing Agents; Trifluoperazine; Triflupromazine | 1963 |
PREDRUG BEHAVIOR AS A PREDICTOR OF RESPONSE TO PHENOTHIAZINES AMONG SCHIZOPHRENICS.
Topics: Antipsychotic Agents; Chlorpromazine; Humans; Perphenazine; Phenobarbital; Phenothiazines; Prochlorperazine; Projective Techniques; Schizophrenia; Triflupromazine | 1963 |
DRUGS, DREAMS AND THE EXPERIMENTAL SUBJECT.
Topics: Anxiety; Dreams; Humans; Hypnosis; Imipramine; Phenobarbital; Prochlorperazine; Sexual Behavior; Sleep | 1963 |
[ANALYSIS OF THE POSSIBLE RELATION OF FETAL DAMAGE AND DRUGS. V. PRELIMINARY STUDY ON THE INFLUENCE OF 4 ANTIEMETICS ON FETAL DEVELOPMENT].
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Antiemetics; Birth Weight; Caffeine; Ephedrine; Female; Fetal Death; Fetal Development; Humans; Infant; Infant, Newborn; Infant, Premature; Meclizine; Pharmacology; Phenobarbital; Pregnancy; Prochlorperazine; Promethazine | 1964 |
LONG-TERM THERAPY WITH NEUROTROPIC DRUGS IN PSYCHIATRIC OUTPATIENTS.
Topics: Biomedical Research; Chlordiazepoxide; Chlorpromazine; Drug Therapy; Mental Disorders; Meprobamate; Outpatients; Phenobarbital; Prochlorperazine; Psychotherapy; Toxicology; Trifluoperazine | 1964 |
CONTROLLED STUDY OF PSYCHIATRIC OUTPATIENT TREATMENT.
Topics: Ambulatory Care; Biomedical Research; Hospitals, Psychiatric; Humans; Meprobamate; MMPI; Neurotic Disorders; Outpatient Clinics, Hospital; Outpatients; Phenobarbital; Placebos; Prochlorperazine; Psychotherapy; Schizophrenia | 1964 |
SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE.
Topics: Chemical Phenomena; Chemistry; Chlorpromazine; Diagnosis, Differential; Drug Therapy; Epilepsy; Eye Manifestations; Intellectual Disability; Melanins; Melanosis; Pathology; Perphenazine; Phenobarbital; Phenylalanine; Photosensitivity Disorders; Pigmentation Disorders; Prochlorperazine; Schizophrenia; Skin Pigmentation; Toxicology | 1965 |